Home › Therapeutic areas › Neurology › Schizophrenia
Schizophrenia (3 companies)
Companies with an active program in Schizophrenia.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| KTTA | Pasithea Therapeutics Corp. | NeurologyOncology | 1 | Phase 1 | 3 |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | CardiovascularDermatologyNeurologyRespiratory Rare | 1 | Phase 3 | 10 |
| VNDA | Vanda Pharmaceuticals Inc. | CardiovascularDermatologyGI/HepatologyHematologyImmunologyInfectious DiseaseNeurologyOphthalmology Rare | 3 | Approved | 26 |
No companies match.